Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series.
about
Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosisCutaneous manifestations of hepatitis C in the era of new antiviral agentsThe expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressantTreatment of hepatitis C-related kidney disease.Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection.Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting Antivirals.Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.Persistence of exhaustion in cured hep C.Persistent hepatitis C virus-associated cryoglobulinemic vasculitis following virus eradication after direct-acting antiviral therapy.Current and future challenges in HCV: insights from an Italian experts panel.Rituximab therapy for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.Persistent Hepatitis C Virus−Associated Cryoglobulinemic Glomerulonephritis in Patients Successfully Treated With Direct-Acting Antiviral Therapy.Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs
P2860
Q26773278-16C9A45B-3419-492B-A868-1A105A2AF8E2Q26773669-92D1F75E-03DE-461E-8EEF-AE3B9688E96FQ30251847-8F5FD94B-EF42-48BD-A3A5-4143205BB7AFQ33710278-C0D9744A-0FE7-4530-9B99-7FFAF1F61E87Q38544801-AF12A65C-4E23-4B2D-B049-5282BC4698BAQ38656396-3CB57681-15DF-42F9-8E17-9C25F4BE4848Q38806948-3D76D6EB-D353-41DD-9F4A-642AF5F8B90AQ38814211-EF20832A-6CD9-4644-9BEB-FA279AEF8F8FQ38909316-AE24A49A-265C-4C7D-8909-0278354690FAQ38933599-F77EBBAA-C6F9-4147-9099-988E39053B88Q40171525-CBEB0869-D5B6-4FAA-B9FC-67E8A39EAF17Q40528517-15B78721-8AC1-4E44-A0FF-2601A4AFB5FEQ40957753-61BCDFA5-C071-47F3-BE17-9AAB29CCE8DFQ45331559-24342BAC-B996-4BA6-B3FF-9832198636C3Q47591971-499D1E24-05FD-4528-AE04-7AF0F1889C24Q49914719-13E29C1F-751D-45DF-9D51-A4F2DFC5B20DQ55456275-2C47F082-F47F-4093-9D6B-805E8846764FQ58733026-F71D2EAD-320E-4D59-8A1E-192B107A43DE
P2860
Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Persistence of mixed cryoglobu ...... ral sofosbuvir: A case series.
@ast
Persistence of mixed cryoglobu ...... ral sofosbuvir: A case series.
@en
type
label
Persistence of mixed cryoglobu ...... ral sofosbuvir: A case series.
@ast
Persistence of mixed cryoglobu ...... ral sofosbuvir: A case series.
@en
prefLabel
Persistence of mixed cryoglobu ...... ral sofosbuvir: A case series.
@ast
Persistence of mixed cryoglobu ...... ral sofosbuvir: A case series.
@en
P2093
P2860
P1476
Persistence of mixed cryoglobu ...... iral sofosbuvir: A case series
@en
P2093
Neeral L Shah
Scott L Cornella
Stephen H Caldwell
Virginia Kelly
P2860
P304
P356
10.1080/00325481.2015.1021660
P407
P577
2015-03-07T00:00:00Z